GSK Investigational Site

Boston PE21 9QS

1 studies enrolling now · 1 studies all time

What they study most

Myelodysplastic Syndromes

Studies at this site

• A Study of Momelotinib in Participants With Low-risk Myelodysplastic Syndrome — Recruiting now